SANTALIS PHARMACEUTICALS INC has a total of 25 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and basic materials chemistry are TAMARKIN DOV, LEGACY HEALTHCARE HOLDING LTD and DERMIPSOR LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | Australia | 5 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Republic of Korea | 2 | |
#7 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Basic materials chemistry | |
#4 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Clements Ian | 25 |
#2 | Levenson Corey | 25 |
#3 | Castella Paul | 25 |
Publication | Filing date | Title |
---|---|---|
EP3359176A1 | Sandalwood oil and its uses related to oral mucositis | |
WO2013112582A1 | Sandalwood oil and its uses related to clostridium infections | |
EP2736504A1 | Sandalwood oil and its uses related to skin disorders | |
AU2011223758A1 | Sandalwood oil and its uses |